Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy-Reference-Cited by-同舟云学术

Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy

Published:2022-04 Issue:4 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Sato Ken¹²^ORCID,Yamazaki Yuichi¹^ORCID,Kanayama Yuki¹^ORCID,Uehara Daisuke¹^ORCID,Tojima Hiroki¹^ORCID,Suga Takayoshi¹^ORCID,Kakizaki Satoru³^ORCID,Sohara Naondo⁴^ORCID,Horiguchi Norio⁵^ORCID,Uraoka Toshio¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan

2. Department of Hepatology Heisei Hidaka Clinic Gunma Japan

3. Department of Gastroenterology National Hospital Organization Takasaki General Medical Center Gunma Japan

4. Sohara Clinic Gunma Japan

5. Department of General Medicine Gunma University Graduate School of Medicine Gunma Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.5690

Reference14 articles.

1. Hepatitis C virus infection in children and adolescents

2. Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition

3. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

4. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan

5. Molecular epidemiology of hepatitis B and C virus infections in Asia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C—Results of a Multicenter EpiTer-2 Study;Journal of Clinical Medicine;2023-11-06